Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$0.63 - $1.59 $158,697 - $400,521
-251,900 Closed
0 $0
Q4 2021

Jan 24, 2022

SELL
$1.27 - $2.42 $3,302 - $6,292
-2,600 Reduced 1.02%
251,900 $320,000
Q3 2021

Oct 25, 2021

SELL
$2.15 - $3.82 $2,150 - $3,820
-1,000 Reduced 0.39%
254,500 $555,000
Q2 2021

Jul 21, 2021

BUY
$2.89 - $4.45 $8,092 - $12,460
2,800 Added 1.11%
255,500 $958,000
Q1 2021

Apr 22, 2021

SELL
$2.9 - $4.09 $20,880 - $29,448
-7,200 Reduced 2.77%
252,700 $824,000
Q3 2020

Nov 06, 2020

BUY
$2.99 - $4.9 $358,202 - $587,020
119,800 Added 85.51%
259,900 $0
Q1 2020

Apr 29, 2020

SELL
$1.83 - $3.45 $1,830 - $3,450
-1,000 Reduced 0.71%
140,100 $326,000
Q3 2019

Oct 24, 2019

BUY
$7.03 - $9.7 $16,872 - $23,280
2,400 Added 1.73%
141,100 $1.17 Million
Q1 2019

May 07, 2019

BUY
$9.08 - $11.84 $13,946 - $18,186
1,536 Added 1.12%
138,700 $1.48 Million
Q4 2018

Jan 28, 2019

BUY
$6.39 - $16.99 $9,048 - $24,057
1,416 Added 1.04%
137,164 $1.2 Million
Q3 2018

Nov 02, 2018

BUY
$16.52 - $24.82 $21,723 - $32,638
1,315 Added 0.98%
135,748 $2.28 Million
Q2 2018

Aug 01, 2018

BUY
$14.31 - $21.75 $18,903 - $28,731
1,321 Added 0.99%
134,433 $2.82 Million
Q4 2017

Feb 12, 2018

BUY
$13.36 - $20.73 $592,075 - $918,691
44,317 Added 49.91%
133,112 $2.52 Million
Q3 2017

Oct 30, 2017

BUY
$8.75 - $14.07 $34,125 - $54,873
3,900 Added 4.59%
88,795 $1.25 Million
Q2 2017

Aug 11, 2017

BUY
N/A
84,895
84,895 $632,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.